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Epidemiological studies suggest that poor nutrition during pregnancy influences 53 
offspring predisposition to experience developmental and psychiatric disorders. Animal 54 
studies have shown that maternal undernutrition leads to behavioral impairment, which 55 
is linked to alterations in monoaminergic systems and inflammation in the brain. In this 56 
study, we focused on the ethanolamine plasmalogen of the brain as a possible 57 
contributor to behavioral disturbances observed in offspring exposed to maternal 58 
undernutrition. Maternal food or protein restriction between gestational day (GD) 5.5 59 
and GD 10.5 resulted in hyperactivity of rat male adult offspring. Genes related to the 60 
phospholipid biosynthesis were found to be activated in the prefrontal cortex (PFC), but 61 
not in the nucleus accumbens or striatum, in the offspring exposed to prenatal 62 
undernutrition. Corresponding to these gene activations, increased ethanolamine 63 
plasmalogen (18:0p-22:6) was observed in the PFC using mass spectrometry imaging. A 64 
high number of crossings and the long time spent in the center area was observed in the 65 
offspring exposed to prenatal undernutrition and was mimicked in adult rats via the 66 
intravenous injection of ethanolamine plasmalogen (18:0p-22:6) incorporated into the 67 
liposome. Additionally, plasmalogen (18:0p-22:6) increased only in the PFC, and not in 68 
the nucleus accumbens or striatum. These results suggest that brain plasmalogen is one 69 
of the key molecules to control behavior and its injection using liposome is a potential 70 
therapeutic approach for cognitive impairment. 71 
 72 
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Significance Statement 76 
Maternal undernutrition correlates to developmental and psychiatric disorders. Here, we 77 
found that maternal undernutrition in early pregnancy led to hyperactivity in rat male 78 
offspring and induced gene activation of phospholipid-synthesizing enzyme and 79 
elevation of ethanolamine plasmalogen (18:0p-22:6) level in the prefrontal cortex (PFC). 80 
Intravenous injection of ethanolamine plasmalogen (18:0p-22:6) incorporated into the 81 
liposome maintained crossing activity and was circumscribed to the center area for a 82 
long time period, in prenatally undernourished offspring with aberrant behavior. 83 
Furthermore, the amount of ethanolamine plasmalogen (18:0p-22:6) increased in the 84 
PFC of the rat after injection. Our result suggests that brain plasmalogen is one of the 85 
key molecules to control behavior and that its injection using liposome is a potential 86 





Epidemiological studies have linked maternal stress during pregnancy, including 89 
malnutrition, infection, daily life stress, and traumatic events, to the presence of 90 
psychological and developmental disorders in offspring (Hoek et al., 1998; Khashan et 91 
al., 2008; Kinney et al., 2008; Marques et al., 2015; Fineberg et al., 2016; Kundakovic 92 
and Jaric, 2017). A previous study suggested that brain development is disrupted by 93 
prenatal exposure to stress, which alters fetal programming by affecting the epigenome, 94 
such as via changes to DNA methylation and histone modification, and induces 95 
behavioral disturbances (Kundakovic and Jaric, 2017). A postmortem study of the brain 96 
of a patient with schizophrenia suggested decreased Reelin and GAD67 expression due 97 
to the hypermethylation of their promoter regions, which was led by the upregulation of 98 
DNA methyltransferase 1 (DNMT1) genes and may be involved in the etiology of 99 
schizophrenia (Kundakovic, 2014). Meanwhile, a Dutch famine study reported the 100 
relationship between prenatal undernutrition during the first trimester and the increased 101 
incidence of schizophrenia (Brown and Susser, 2008). These reports suggest that 102 
maternal stress may alter brain function through disturbances in the neurotransmission 103 
of certain systems, such as the GABAergic system. In fact, restraint stress on mice 104 
during pregnancy leads to the overexpression of DNMT1 and DNMT3a mRNA, which 105 
is accompanied by the downregulation of Reelin and GAD67 protein levels, as well as 106 
glutamine receptor protein from the hypermethylation of their promoter regions in the 107 
frontal cortex. This cascade of events induced a schizophrenia-like phenotype 108 
observable in behavioral tests performed on the male offspring after birth (Matrisciano 109 
et al., 2013). Prenatal stress is thus associated with a predisposition toward 110 




also been shown to affect the dopamine system and neuronal excitability, resulting in a 112 
decrease in anxiety-like behavior, while protein restriction results in deficits in pre-pulse 113 
inhibition and locomotor activity (Markham and Koenig, 2011; Amaral et al., 2015). 114 
Based on these findings, various neurotransmitter systems, including monoamine, 115 
GABAergic, and glutaminergic systems, appear to be viable therapeutic targets for 116 
treating behavioral disturbances induced by prenatal stress; however, membrane lipids 117 
also seemed to differ between the brains of patients with psychiatric disorders and those 118 
without such disorders, and little is known regarding the underlying mechanisms of this 119 
process (Ghosh et al., 2017). Therefore, we hypothesized that behavioral disturbance 120 
due to early prenatal undernutrition is led by aberrant brain phospholipid metabolism 121 
via fetal programming. In this study, we focused on alterations in the composition of 122 
brain phospholipids that are induced by prenatal undernutrition, and we have identified 123 
a candidate phospholipid to control behavior. 124 




Materials and methods 126 
Animals 127 
All animal procedures were approved by the Institutional Review Board of the Shiga 128 
University of Medical Science Animal Care and Use Committee (2011-8-1, 2014-3-7, 129 
2015-12-1, and 2019-4-2). For experiments investigating maternal undernutrition, 130 
9-week-old male (body weight [BW], 250–280 g) and 8-week-old female (BW, 160–131 
190 g) Wistar rats were obtained from CLEA Japan, Inc. (Tokyo, Japan). Six-week-old 132 
male rats were obtained for experiments involving phosphatidylethanolamine (PE) 133 
injection. All rats were housed under a 12-h light:dark cycle (lights were turned on at 134 
08:00) and were allowed to acclimate for greater than 1 week. 135 
Diet 136 
Female rats were acclimated to a standard diet for pregnant rats (AIN-93G), containing 137 
20% casein for 2 days prior to mating, for which each female was housed with one male 138 
overnight. We defined gestational day (GD)0 as the day when a vaginal plug was 139 
observed. Pregnant rats were randomly assigned to the ad libitum (AL) group, the 140 
food-restriction (F) group, or the isocaloric, low-protein-diet (LPD) group, and 141 
subjected to undernutrition from GD5.5 to GD10.5 or from the day of blastocyst 142 
implantation to the day just before the closure of the neural tube (Fig. 1A) (Erb, 2006). 143 
In humans, this period is comparable to the days from E6.5 to approximately E30, 144 
which is nearing the first half of the first trimester (Bystron et al., 2008; Schoenwolf et 145 
al., 2015). Neural stem cells, and not neurons, exist in the telencephalon because this 146 
period is prior to neurogenesis (Götz and Huttner, 2005; Bystron et al., 2008). The F 147 




the AL group (eight dams). The rationale is that daily rations fell to no more than 800 149 
kcal during the Dutch famine that occurred between December 1944 and April 1945, 150 
representing 40% of rations (>2000 calories) after June 1945 (Roseboom et al., 2001). 151 
The LPD group (five dams) was fed a diet containing 9% casein. After delivery, pups 152 
were culled to produce litters of eight offspring (four males and four females) per a dam 153 
on postnatal day (P)4. During lactation, the dams were fed CE-2, a standard pellet chow 154 
for rearing and breeding. Subsequently, the offspring were weaned on P28, and 155 
afterward, they were fed CE-2 ad libitum. Male offspring were used in this study 156 
because male humans show a higher risk of neuropsychiatric or neurobehavioral 157 
disorders (e.g., schizophrenia, attention deficit hyperactivity disorder [ADHD], and 158 
autism spectrum disorder [ASD]), than females (Aleman et al., 2003; Werling and 159 
Geschwind, 2013; Arnett et al., 2015). Furthermore, sex differences in ADHD and ASD 160 
may be, in part, genetically mediated (Werling and Geschwind, 2013; Arnett et al., 161 
2015). The male offspring experienced handling once a week after weaning, and body 162 
weight of the offspring were measured at 9 and 12 weeks of age. 163 
Preparation of liposomes 164 
Large unilamellar liposomes composed of egg phosphatidylcholine (PC) and 165 
C18:0-22:6 plasmalogen PE (PlsEtn) or C16:0-18:1 diacyl phosphatidylethanolamine 166 
(POPE) were prepared by the extrusion method (Morita et al., 2008). Briefly, a thin film 167 
was obtained by evaporating the lipid chloroform solution and was subsequently 168 
hydrated with saline so that the concentrations of egg PC and PE (18:0p-22:6) (Avanti, 169 
AL) were 8 mg/mL and 2 mg/mL, respectively, for PE liposomes (PELs). Similarly, 170 
mixed solutions of PE (16:0-18:1) and egg PC were prepared at the same concentration 171 




mg/mL) with no PE was prepared. After five rounds of freezing and thawing, the lipid 173 
suspension was extruded through a polycarbonate filter with 100-nm pore size. 174 
Behavioral test 175 
Effects of prenatal undernutrition on behavior 176 
From June to October, the locomotor activity of the male offspring was evaluated by the 177 
open-field test at 8 weeks of age for the AL (n = 32 from 8 dams), LPD (n = 18 from 5 178 
dams), 50F (n = 13 from 4 dams), and 40F (n = 17 from 6 dams) groups and at 12 179 
weeks for the AL (n = 18 from 5 dams), LPD (n = 19 from 5 dams), and 50F (n = 14 180 
from 5 dams) groups, to examine the impact of maternal undernutrition on behavior. 181 
Behavioral data that included device errors in tracing animals were excluded. The 182 
apparatus, measuring 90 cm in diameter and 45 cm in height, was used to monitor the 183 
behavior of rats, and the behavior was recorded for 10 min under 9 lux of light. Data 184 
were analyzed using the Limelight video tracking system (Actimetrics, IL, USA). The 185 
distance traveled and the time spent in the center was measured under the following 186 
analysis conditions: the open field was divided into the center and peripheral regions so 187 
that 1) the center region was bordered by a concentric circle passing through the 188 
midpoint of the radius of the open field (Condition 1 and 2) the area of the center region 189 
(A1) was the same as that of the peripheral region (A2) (Condition 2). The former 190 
condition was selected to allow crossing behavior to be analyzed. 191 
Effects of plasmalogen (18:0p-22:6) on behavior 192 
To examine the effect of PE (18:0p-22:6), the locomotor activity of male rats was 193 
evaluated before and after PE (18:0p-22:6) injection (for 8- and 14-week-old offspring, 194 
respectively). Rats were assigned to two different groups based on the results of 195 




evenly divided among the groups. A PEL or CL suspension (1 mL/kg BW) was injected 197 
into the tail vein at 14 weeks of age, and the second injection of liposome suspension 198 
was performed 2 days later. The rats in the PEL (n = 6) and CL (n = 7) groups were 199 
subjected to the open-field test or the elevated plus maze test (PEL: n = 6, CL: n = 6) 1 200 
day or 4 days after the second injection, respectively. Behavioral data of one CL rat 201 
acquired by using the elevated plus maze test was excluded because it included device 202 
errors in tracing animals. In the elevated plus maze test, rats were placed in the central 203 
square platform facing the closed arms, and their behavior was recorded for 250 204 
seconds under 8, 10, and 4 lux of light at the central square platform, facing the open 205 
arms and closed arms, respectively (Hino et al., 2019). Time spent in the open and 206 
closed arms was measured in this test. To verify the specific effect of PlsEtn 207 
(18:0p-22:6) on behavior, the alteration of locomotor activity was examined before and 208 
after POPEL, CL, or saline injection. Male rats were assigned to three different groups 209 
based on the results of the crossing analysis, and behavior was evaluated for POPEL (n 210 
= 5), CL (n = 5), and saline injection (n = 4) groups. This experiment was conducted 211 
separately from the PEL injection study. The experimental groups allocated in this study 212 
are listed in Table 2. 213 
Metabolic profiling of plasma and cerebrospinal fluid (CSF) 214 
Blood samples were collected from male offspring (AL: four dams and seven litters, 215 
40F: four dams and six litters) and CSF (AL: four dams and seven litters, 40F: four 216 
dams and five litters) at 9 weeks of age. CSF samples that got mixed with blood were 217 
excluded from the analysis. Rats were anesthetized with sodium pentobarbital solution 218 
(35 mg/kg, intraperitoneally) during the light phase (16:00–18:00). They were placed in 219 




from the cisterna magna. Then, after decapitation, 5 mL of blood was collected in test 221 
tubes containing EDTA-2Na. The plasma was collected after centrifugation of the blood 222 
at 2,000 × g for 15 min. Samples were stored at −80°C until use. 223 
Hydrophilic metabolites were extracted using the MeOH-CHCl3 method according to 224 
the procedure detailed in previous reports (Tsugawa et al., 2011; Nishiumi et al., 2012). 225 
Fifty μL of plasma or CSF was mixed with 250 μL of a solvent mixture 226 
(MeOH:H2O:CHCl3, 2.5:1:1, v/v/v) containing 20 μL of 0.25 mg/mL 2-isopropylmalic 227 
acid (Sigma-Aldrich, Tokyo, Japan) as the internal standard. The mixture was then 228 
shaken at 37°C for 30 min and centrifuged at 16,000 × g for 5 min at 4°C. Then, 225 μL 229 
of supernatant was mixed with 200 μL of distilled water, and the solution was 230 
centrifuged at 16,000 × g for 5 min at 4°C. The resultant supernatant (250 μL) 231 
containing hydrophilic primary metabolites was collected and lyophilized using a freeze 232 
dryer. For oximation, 40 μL of 20 mg/mL methoxyamine hydrochloride (Sigma-Aldrich, 233 
Tokyo, Japan) dissolved in pyridine was mixed with a lyophilized sample, and the 234 
mixture was then shaken at 30°C for 90 min. For derivation, 20 μL of 235 
N-methyl-N-trimethylsilyl-trifluoroacetamide (MSTFA) (GL Science, Tokyo, Japan) 236 
was added, and the mixture was shaken at 37°C for 30 min. The mixture was then 237 
centrifuged at 16,000 × g for 5 min at 4°C, and the resultant supernatant was subjected 238 
to gas chromatography–mass spectrometry (GC–MS) analysis. 239 
GC–MS analysis was performed by using a GCMS-QP2010 Ultra device (Shimadzu 240 
Co., Kyoto, Japan) with a fused-silica capillary column (CP-SIL 8 CB low bleed/MS; 241 
30 m × 0.25 mm inner diameter, film thickness: 0.25 μm; Agilent Co., Palo Alto, CA, 242 
USA). The front inlet temperature was set at 230°C. The flow rate of helium gas 243 




and then raised by 15°C/min to 330°C and held for 6 min. The transfer-line and 245 
ion-source temperatures were 250°C and 200°C, respectively. Twenty scans per second 246 
were recorded over the mass range of 85–500 m/z by using the Advanced Scanning 247 
Speed Protocol (ASSP, Shimadzu Co., Kyoto, Japan). 248 
Raw data were exported in netCDF format, and peak detection and alignment were 249 
performed by using MetAlign software (Wageningen UR, The Netherlands). The 250 
resulting data were exported in CSV format and then analyzed with in-house analytical 251 
software (AIoutput), which enabled peak identification and semi-quantification by using 252 
an in-house metabolite library (Tsugawa et al., 2011; Nishiumi et al., 2012). For 253 
semi-quantification, the peak height of a particular ion for each metabolite was 254 
normalized to the peak height of the specified ion of 2-isopropylmalic acid (the internal 255 
standard). 256 
Brain sections 257 
According to previous reports, lesions in the medial PFC cause alterations in the 258 
locomotor activity of rats (Jinks and McGregor, 1997; Fritts et al., 1998). Moreover, the 259 
nucleus accumbens (NAcc) and striatum (CPu) receive input from the PFC and are 260 
associated with locomotor activity and impulsivity (Moreno et al., 2013; Spencer et al., 261 
2015; Scofield et al., 2016; Zhu et al., 2016; Dahoun et al., 2017). Hence, sections of 262 
PFC, NAcc, and CPu were subjected to gene expression and phospholipid analyses, and 263 
immunohistochemistry. Male offspring of 9 weeks of age from the maternal 264 
undernutrition experiment and male rats injected with PEL or CL at 14 weeks of age (at 265 
10 hours after the elevated plus maze test) were anesthetized and euthanized with 266 
sodium pentobarbital solution (100 mg/kg, ip). Brain samples from the AL (four dams 267 




were immediately dissected out and frozen in dry ice. Cryosections of the brain were cut 269 
at a thickness of 10 μm before use for gene expression and phospholipid analyses. 270 
Greater than eight sections of the prefrontal cortex (PFC) every 200 m, greater than six 271 
sections of NAcc (Nucleus accumbens) every 80 m, and greater than seven sections of 272 
CPu (Caudate putamen) every 80 m were placed on Platinum Pro (Matsunami, Osaka, 273 
Japan) or polyethylene naphthalate membrane slides (Leica Microsystems, Wetzlar, 274 
Germany) for immunohistochemistry or gene expression analysis, respectively. Sections 275 
at 0.8 mm and 2 mm from the frontal end of the cerebral cortex, a section at 0.32 mm 276 
from the anterior end of the NAcc, and a section at 0.48 mm from the anterior end of the 277 
CPu were placed on indium tin oxide (ITO)-coated glass slides (Bruker Daltronics, 278 
Bremen, Germany) for phospholipid analysis. 279 
Gene expression 280 
The PFC, NAcc, and CPu of male offspring in the AL and 40F groups were dissected 281 
and collected from brain sections by a laser microdissection system (LMD6000, Leica 282 
Microsystems, Wetzlar, Germany). Gene expression analysis was performed according 283 
to the protocol described in the previous report (Kimura et al., 2018). Isolated total RNA 284 
was converted to cDNA via reverse transcription (RT) and amplified using the Ovation 285 
PicoSL WTA system V2 (NuGEN Technologies, Inc., San Carlos, CA, USA). The 286 
mRNA expression levels were estimated using quantitative real-time PCR (RT-qPCR) 287 
analysis using a LightCycler 480 system (Roche Diagnostics GmbH, Mannheim, 288 
Germany) with SYBR Premix Ex Taq II polymerase (Takara Bio, Kusatsu, Japan). The 289 
RT-qPCR reaction was performed in duplicates, and comparative Cq values of the target 290 
genes (Table 1) normalized to B2m, a reference gene, were compared between the AL 291 




Counting microglial cells and activated microglial cells in PFC 293 
In each rat, ten or more brain sections at approximately 4.8 to 2.6 rostral to the bregma 294 
were fixed with 4% paraformaldehyde at room temperature for 30 min, incubated with 295 
rabbit anti-Iba1 antibody (dilution, 1:500; Wako Cat# 019-19741, RRID:AB_839504) 296 
and mouse anti-CD11b (dilution, 1:300; Bio-Rad / AbD Serotec Cat# MCA275R, 297 
RRID:AB_321302), and then incubated with goat anti-rabbit IgG (H&L) conjugated 298 
with DyLight 488 (dilution, 1:500; Abcam Cat# ab96895, RRID:AB_10679405) and 299 
goat anti-mouse IgG (H&L) conjugated with DyLight 549 (dilution, 1:500; Rockland 300 
Cat# 610-142-121, RRID:AB_1057533). Sections were stained with 301 
4′,6-diamidino-2-phenylindole (DAPI), and the numbers of all Iba1-expressing 302 
microglial cells and CD11b-labeled activated microglial cells were counted in the 303 
medial PFC by using a fluorescence microscope (IX83, Olympus, Tokyo, Japan). The 304 
density of those cells was then compared between offspring in the AL and 40F groups. 305 
Matrix-assisted laser desorption/ionization-imaging mass spectrometry 306 
(MALDI-IMS) 307 
MALDI-IMS was performed by using the PFC, NAcc, and CPu samples in both 308 
experiments as previously described (Hossen et al., 2015; Sugiyama et al., 2015). 309 
Tissues on ITO-coated glass slides were subjected to matrix application by the 310 
sublimation/deposition method, with 1 g of 9-AA sublimated at 210°C in order for the 311 
deposition thickness to reach 1.0 μm by using the iMLayer device (Shimadzu, Kyoto, 312 
Japan). Experiments were performed by using a mass microscope, a prototype of the 313 
iMScope equipped with a 355-nm Nd:YAG laser (Shimadzu, Kyoto, Japan). Negative 314 
ions from a sample area of 30 m × 30 m on the PFC, NAcc, and CPu samples were 315 




reference were laid together with rat brain sections of 40F and AL offspring, and the rats 317 
injected with PEL and CL and were used to correct for differences in peak intensity due 318 
to differences in sample preparation between slides (Fig. 2). The peaks of 52 PE, 16 319 
phosphatidylserine (PS), 14 phosphatidylinositol (PI), 10 lysophosphatidylethanolamine 320 
(lysoPE), and 4 lysophosphatidylinositol (lysoPI) were detected (Taguchi and Ishikawa, 321 
2010). The peak intensity of each individual phospholipid was corrected using the 322 
average intensity of the corresponding phospholipid of the mouse references. The 323 
average peak intensities of the PFC, NAcc, and CPu, respectively, were compared 324 
between the AL and 40F groups and between the PEL and CL groups. 325 
To identify the peak assigned at m/z 774.5 as the peak of PE (18:0p-22:6), we 326 
performed MALDI tandem mass spectrometry (MS/MS) using the mass microscope 327 
described above (Sugiyama et al., 2015) and identified PE (18:0p-22:6) via 328 
collision-induced dissociation (CID) (Zemski Berry et al., 2014). 329 
Blood cells 330 
Blood was collected from 14-week-old male rats for the PEL and CL injection 331 
experiment. Whole blood cells were washed with saline, applied to a 12-well 332 
flexiPERM® plate (Sarstedt, Tokyo, Japan), and affixed to an ITO-coated glass slide 333 
(Matsunami Glass Industries, Osaka, Japan), of which the surface was coated with 334 
poly-L-lysine (Hossen et al., 2015) to ensure that the blood cells were confluent. Blood 335 
cells were centrifuged to attach the cells to the surface of the glass slide, fixed with 336 
0.25% glutaraldehyde for 5 min, and rinsed three times with 150 mM ammonium 337 
acetate buffer (pH 7.5). Samples were dried and subjected to MALDI-IMS to examine 338 
the phospholipid content in the blood cells Briefly, negative ions from a sample area of 339 




peak intensity of PE (18:0p-22:6) to the total peak intensity of all lipids was compared 341 
between the PEL and CL groups for the blood cells collected from the rats of these 342 
groups. 343 
Statistical analysis 344 
All data are presented as means ± standard deviations. Differences in body weight and 345 
locomotor activities in the adult offspring between the 40F, 50F, LPD, or AL groups 346 
were identified using one-way analysis of variance (one-way ANOVA) followed by 347 
Dunnett’s multiple comparison test to examine which treatment leads to the disturbance 348 
of the body growth and the behavior in the offspring compared with ad libitum food 349 
access. Analysis of covariance (ANCOVA) was applied to compare changes in 350 
behaviors after liposome injection using the behavioral data at 14 weeks of age as the 351 
dependent variable, data at 8 weeks of age as the covariate, and group allocation (CL 352 
and PEL groups, or CL, POPEL, and saline groups) as the independent variable. 353 
Metabolites in plasma and CSF, gene expression levels, the number of microglia, and 354 
phospholipid levels in the brain were compared between the 40F and AL groups by 355 
using the unpaired Student’s t-test. Phospholipid levels in the blood cells were 356 
compared among CL, PEL, and saline groups using one-way ANOVA followed by 357 
Tukey’s HSD test. Differences were considered significant when p < 0.05 and Cohen’s 358 
d was calculated to assess the effect size. ANCOVA was performed using JMP version 359 
14.0 software (SAS Institute Inc., Cary, NC, USA). The other statistical analyses were 360 
performed using IBM-SPSS Statistics 22.0 software (IBM-SPSS, Inc., Chicago, IL, 361 
USA). 362 





Body weight of male rat offspring 365 
No significant difference was observed between the body weight of male offspring of 366 
40F and that of AL, 50F, or LPD at 9 weeks of age. However, the body weight of the 367 
male offspring was significantly lower in the 50F and LPD groups (p = 0.06 and 0.10, 368 
respectively) compared with that of the male offspring in the AL group using Dunnett’s 369 
test following one-way ANOVA (p = 0.002,  = 0.159 for the main effect) (Table 3). 370 
The body weight of 50F and LPD male offspring became similar to that of AL offspring 371 
at 12 weeks of age (Table 3). 372 
Maternal undernutrition during early pregnancy leads to hyperactivity in rat offspring 373 
To study the effect of nutritional stress during early embryonic stages on postnatal 374 
behavior, the open-field test was performed for adult male offsprings delivered from 375 
dams that underwent food restriction from GD 5.5 to GD 10.5. In this study, the 376 
behavioral tests performed for offspring at 8 weeks of age revealed that the total 377 
distance traveled, the distance traveled in the center area, and the frequency of crossings 378 
were significantly increased for males from the 40F group (p = 0.028, p = 0.036, and p 379 
< 0.001, respectively), the 50F group (p < 0.001, p = 0.004, and p < 0.001, respectively), 380 
and the LPD group (p = 0.026, p = 0.030, and p = 0.016, respectively) compared with 381 
the corresponding findings for males in the AL group, in which dams were fed ad 382 
libitum, using Dunnett’s test following one-way ANOVA (total distance traveled: p < 383 
0.001,  = 0. 209; distance traveled in the center: p = 0.003,  = 0.167; 384 
frequency of crossing: p < 0.001,  = 0.439 for the main effect; Fig. 1B–D). There 385 




Condition 1 of the open-field test (Fig. 1E), but the time spent in the center area was 387 
longer for both the 40F (p = 0.015) and 50F (p = 0.037) groups compared with the AL 388 
group in Condition 2, where the radius of the center area represented 70% of the open 389 
field (Dunnett’s test following one-way ANOVA: p = 0.011,  = 0. 135 for the 390 
main effect; Fig. 1F). Maternal protein restriction during early pregnancy, in part, 391 
contributed to the hyperactivity of the offspring. Increased total distance traveled (LPD: 392 
p < 0.001, 50F: p < 0.001), the distance traveled in the center area (LPD: p < 0.001, 393 
50F: p = 0.006), the frequency of crossings (LPD: p = 0.001, 50F: p = 0.011), and the 394 
time spent in the center area in Conditions 1 (LPD: p = 0.020, 50F: p = 0.015) and 2 395 
(LPD: p = 0.001, 50F: p = 0.019) were observed even at 12 weeks of age for offspring 396 
from the 50F and LPD groups compared with the AL group (one-way ANOVA with 397 
Dunnett’s test), although this parameter was not examined for the offspring of the 40F 398 
group (Fig. 1G–K). However, locomotor activity did not correspond to the body weight 399 
at 9 and 12 weeks of age (Fig. 1 and Table 3). The p value and effect size for the main 400 
effect in one-way ANOVA of locomotor activities at 12 weeks of age were as follows: 401 
total distance traveled: p < 0.001,  = 0. 333; distance traveled in the center: p < 402 
0.001,  = 0.298; frequency of crossing: p = 0.001,  = 0.237; time spent in the 403 
center area: p = 0.011,  = 0.173 in Condition 1 and p = 0.001,  = 0.246 in 404 
Condition 2. 405 
Glyco- and amino-metabolisms are altered in the offspring 406 
In this study, metabolome profiling of the plasma and CSF was performed for offspring 407 
at 9 weeks of age (after behavioral tests) of the 40F group, which displayed the most 408 




of glycerol, which is the source of diacylglycerol in phospholipids, was increased in 410 
blood plasma (p = 0.014, d =1.57 ) and CSF (p = 0.001, d = 1.50) in the 40F group 411 
compared with the AL group (Fig. 3A). In plasma, 1,5-anhydro-D-glucitol (p = 0.038, d 412 
= 1.61) and 2-aminoethanol (p = 0.014, d = 1.21) were also increased in the offspring of 413 
the 40F group (Fig. 3A and Fig. 3-1). 2-aminoethanol is converted to O-phosphoethanol 414 
amine, and finally transferred to diacylglycerol or 1-O-alkyl-2-acyl-sn-glycerol to 415 
produce PE (Braverman and Moser, 2012; Vance, 2015). 416 
Microglial cell activation in the PFC is not induced by prenatal undernutrition 417 
The cell densities of Iba1-positive microglial cells and those of both Iba1- and 418 
CD11b-positive activated microglial cells in the PFC were not significantly different 419 
between the AL and 40F groups (Fig. 3B–D). Additionally, no change in the ratio of 420 
activated glial cells to total microglial cells was observed between the AL and 40F 421 
groups (Fig. 3E); therefore, microglial cell activation was not enhanced by prenatal 422 
undernutrition during the early embryonic period. 423 
Expression of genes related to phospholipid biosynthesis is increased in the PFC 424 
of rats exposed to prenatal undernutrition 425 
To examine the modulation of the phospholipid biosynthetic pathway in the PFC, NAcc, 426 
and CPu in offspring (Fig. 4) exposed to maternal undernutrition, gene expression of the 427 
enzymes involved in this pathway was examined. In the brain, dihydroxyacetone 428 
phosphate (DHAP) is the main precursor of phospholipids. DHAP is synthesized from 429 
glucose and serves as a precursor of diacylglycerol, which constitutes the hydrophobic 430 
tail of phospholipids such as PC, PE, and PS (Benjamins et al., 2011). Diacylglycerol 431 
may be, in part, formed from glycerol, mediated through glycerol 3-phosphate (Fig. 4) 432 




ether-phospholipid, plasmalogen (Braverman and Moser, 2012). In the first step of the 434 
synthetic pathway of plasmalogen, as well as that for diacyl phospholipids, hexokinase 435 
1 (Hk1) is one of the key enzymes in the regulation of the carbohydrate metabolic rate, 436 
which converts glucose to glucose 6-phosphate (McKenna et al., 2011). The expression 437 
of Hk1 was enhanced in 40F offspring (p = 0.016, d = 1.68), although 438 
phosphofructokinase (Pfk1), the rate-limiting enzyme in glycolysis (McKenna et al., 439 
2011), was not different in the PFC between 40F and control offspring (Fig. 5A, 5B, and 440 
5-1). Regarding the synthesis of the hydrophobic tail of phospholipids, the gene 441 
expression of the following enzymes related to diacylglycerol and CDP-diacylglycerol 442 
synthesis were elevated in the PFC of the offspring of the 40F group: 443 
glyceronephosphate O-acyltransferase (Gnpat) (p = 0.001, d = 2.32), glycerol kinase (p 444 
= 0.016, d = 1.60), glycerol-3-phosphate transferase (Gpat) 1, 3, and 4 (p = 0.027, 0.032, 445 
and 0.030, and d = 1.46, 1.50, and 1.57, respectively), and phosphatidate 446 
cytidylyltransferase 2 (p = 0.045, d = 1.25). Regarding the synthesis of the hydrophilic 447 
head of phospholipids, the gene expression of ethanolamine kinase for PE (p = 0.033, d 448 
= 1.37), phosphate cytidylyltransferase 1, choline, alpha (Pcyt1a) (p = 0.013, d = 1.68) 449 
and phosphate cytidylyltransferase 1, choline, and beta (Pcyt1b) (p = 0.010, d = 1.73) 450 
for PC; and phosphatidylserine synthase 1 (Ptdss1) for PS (p = 0.007, d = 1.86) was 451 
elevated in the PFC of the offspring of the 40F group (Fig. 5B). In contrast, 452 
plasmalogen is synthesized from ethanolamine or choline and 453 
1-O-alkyl-2-acyl-sn-glycerol, which is produced from fatty alcohol and 454 
1-O-alkyl-DHAP (Braverman and Moser, 2012). In this pathway, 1-O-alkyl-DHAP is 455 
generated from DHAP by GNPAT and alkylglycerone phosphate synthase (AGPS) 456 




these enzymes were found to be activated whereas the fatty acyl-CoA reductase 1 458 
(Far1) gene expression, which is a potential rate-limiting enzyme (Honsho and Fujiki, 459 
2017), was not altered in the offspring of the 40F group compared with that of the 460 
offspring of the AL group (Fig. 5B and 5-1). In contrast to the PFC, Gpat1 (p = 0.036, d 461 
= 1.39) and Pcyt1b (p = 0.008, d = 1.65) expression was lower in the offspring of the 462 
40F group than in the offspring of the AL group in the NAcc and CPu, respectively, 463 
although the expression of the other genes, which showed altered expression in the PFC, 464 
was not changed in the NAcc and CPu (Fig. 5A, B and 5-1). Furthermore, between the 465 
offspring of the AL group and the 40F group, in the PFC, no significant difference was 466 
observed in the expression of the calcium-independent phospholipase A2 (iPla2) gene, 467 
which catalyzes phospholipids (Yeagle, 2016), or that of sphingomyelin synthase 1 468 
(Sgms1) and sphingomyelin phosphodiesterase 3 (Smpd3), which convert PC into 469 
sphingomyelin and ceramide (Vance, 2015), respectively (Fig. 5-1). As described above, 470 
our results indicated that the genes of enzymes related to plasmalogen, as well as diacyl 471 
phospholipids, were activated in the PFC of offspring exposed to prenatal 472 
undernourishment. Alternatively, gene expression was not affected with respect to 473 
aquaporin 9 (Aqp9; a channel permeable to glycerol and water) (Badaut and Regli, 474 
2004) or major facilitator superfamily domain containing 2A (Mfsd2a; the major 475 
transporter for docosahexaenoic acid [DHA]) (Nguyen et al., 2014). Additionally, the 476 
expression of apolipoprotein E, which is involved in lipid transport (Liao et al., 2017), 477 
was not altered by prenatal undernutrition (Fig. 5-1). 478 
Phospholipid composition is altered in the cerebrum by maternal undernutrition 479 
The peak intensity of m/z 774.5 PE in the PFC of the offspring of the 40F group was 480 




and D). CID of m/z774.5 yielded product ions at m/z 283.2, 327.2, and 464.3; therefore, 482 
m/z 774.5 was identified as PE (18:0p-22:6) (Fig. 5E). Additionally, lysoPE (20:1) in 483 
the PFC of 40F offspring was 1.7-fold that of the AL offspring (p = 0.037, d = 1.36); 484 
however, no significant difference was observed between groups for the other 485 
phospholipids examined (Fig. 5-2). In contrast, the peak intensities of PE (20:1-22:6), 486 
lysoPE (20:4), and lysoPE (22:6) in the NAcc (p = 0.045, 0.034, and 0.031, and d = 487 
1.30, 1.39, and 1.42, respectively), and of lysoPE (20:4) and lysoPE (22:6) in the CPu 488 
(p = 0.004 and 0.019, and d = 2.07 and 1.57, respectively) were attenuated in the 489 
offspring of the 40F group compared with the offspring of the AL group. However, no 490 
phospholipid showed enhanced peak intensity in the NAcc and CPu of the offspring of 491 
the 40F group (Fig. 5D and 5-2). On the other hand, only PE (18:0p-22:6) in the PFC 492 
varied in amount among PlsEtn examined in this study by prenatal undernutrition (Fig. 493 
5D, Table 4). From the perspective of the tail forms of the phospholipids, PE 494 
(18:0p-22:6) in the PFC exclusively increased in the offspring of the 40F group among 495 
DHA (22:6)-containing phospholipids, although some phospholipids containing DHA or 496 
arachidonic acid (AA, 20:4) decreased in the NAcc and CPu (Fig. 5D, Table 4). 497 
PlsEtn affects the behavior of adult rats 498 
To examine the effect of PE (18:0p-22:6) on rat behavior, rats were subjected to the 499 
open-field test and elevated plus maze test after intravenous injection of PEL or CL (Fig. 500 
6A). The age-related decline in the frequency of crossing, as well as the difference in 501 
the time spent in the center area (Condition 2) was reduced in rats in the PEL group 502 
compared with rats in the CL group (Fig. 6B). However, no significant difference was 503 
observed in the results of the elevated plus maze test between the PEL and CL groups 504 




POPEL, CL, and saline on rat behavior (Fig. 6C and 6E). Four days after the second 506 
injection of PEL (Fig. 6A), the amount of PE (18:0p-22:6) in the PFC (p = 0.019, d = 507 
3.02), but not that in the NAcc or CPu, was still greater in the PEL group than in the CL 508 
group, while no significant difference was observed in the amount of the other PlsEtn 509 
between these groups, as determined by MALDI-IMS (Fig. 6F and Fig. 6-1). The 510 
increased amount of PE (18:0p-22:6) in the PFC of the PEL group was verified in 511 
another PE injection experiment (Fig. 6-2). Meanwhile, the amounts of PE (22:6-24:6) 512 
(p = 0.019, d = 3.02), PE (24:4-22:6) (p = 0.013, d = 3.36), PS (16:0-22:6) (p < 0.001, d 513 
= 9.02), PI (16:1-18:1) (p = 0.004, d = 4.56), and lysoPE (18:1) (p < 0.001, d = 8.58), all 514 
of which are acyl phospholipids, were lower in the PFC in the PEL group than in the CL 515 
group (Fig. 6F). The amounts of PE (16:0-18:1) (NAcc; p = 0.041, d = 2.08, CPu: p = 516 
0.016, d = 2.68) and lysoPE (20:1) (NAcc; p = 0.012, d = 2.91, CPu: p = 0.033, d = 517 
2.64) were lower in the NAcc and CPu for the PEL group than in the CL-group. The 518 
amounts of PE (16:1-20:5), PI (18:0-22:4), and plasmalogen PE (18:1p-20:1) were also 519 
decreased in the NAcc of the PEL group (p = 0.008, 0.032, and 0.023, and d = 3.18, 520 
0.85, and 2.51, respectively), whereas those of lysoPE (18:1), lysoPE (22:6), and 521 
lysoPE (22:4) were decreased in the CPu of that group (p = 0.039, 0.033, and 0.026, and 522 
d = 2.13, 2.55, and 2.42, respectively; Fig. 6F). To verify that increased PE (18:0p-22:6) 523 
in the PFC was not ascribed to PE incorporated into the blood cells from liposomes 524 
inside blood vessels, PE (18:0p-22:6) in blood cells was measured by MALDI-IMS. 525 
The ratio of PE (18:0p-22:6) to total lipids for the PEL group did not differ from that for 526 
the CL group (Fig. 6G). Thus, PE (18:0p-22:6) was incorporated at least into the PFC, 527 
but not blood cells, after the injection of PE liposomes. Similar to prenatal 528 




and PI containing DHA or AA (Fig. 6F, Table 5). Furthermore, most phospholipids that 530 
varied in amount after exposure to prenatal undernutrition were not altered by PEL 531 
injection, although lyso PE (22:6) was reduced in both 40F offspring and PEL-injected 532 





The findings of our study suggest that changes in phospholipid composition led by 535 
prenatal undernutrition is associated with hyperactivity in rats, and plasmalogen PE 536 
(18:0p-22:6) injection reproduces a part of hyperactive behaviors. Regarding the cell 537 
membrane, plasmalogens constitute approximately 20% of total phospholipids, both in 538 
the rat cerebral cortex and the human brain (Braverman and Moser, 2012). In humans, 539 
ethanolamine plasmalogen constitute 57% and 84% of the glycerophosphoethanolamine 540 
fraction of the gray and white matter of the frontal cortex, respectively (Braverman and 541 
Moser, 2012). Neurons and myelin are rich in plasmalogens, which decrease membrane 542 
fluidity, increase membrane rigidity, and allow tight packing of phospholipids in the 543 
membrane (Dean and Lodhi, 2017). Plasmalogens play a role in membrane trafficking 544 
and fusion processes, Schwann cell differentiation and function, molecule antioxidation, 545 
and inhibition of neuronal apoptotic signaling. Hence, a deficiency of plasmalogens 546 
induces impairments of neurotransmitter release from synaptosomes to the presynaptic 547 
cleft, myelination and axonal sorting by Schwann cells, and neuronal apoptosis 548 
signaling (Dean and Lodhi, 2017). These reports suggest the clinical importance of 549 
plasmalogens to the nervous system. The amyloid  peptide, which is rich in the brains 550 
of patients with Alzheimer’s disease, reduces AGPS protein stability and decreases 551 
plasmalogen PE levels in patients with Alzheimer’s disease (Han et al., 2001; Grimm et 552 
al., 2011). Recently, Hossain et al. reported that inflammatory stimuli, such as the 553 
administration of lipopolysaccharide (LPS) or polyriboinosinic:polyribocytidylic acid, 554 
reduce plasmalogens in murine glial cells through the activation of NF- B, which 555 
downregulates Gnpat through increased c-Myc recruitment to the Gnpat promoter 556 




aging, exposure to chronic restraint stress, and injection of LPS; furthermore, the 558 
reduction of plasmalogen induced activation of microglial cells and elevated expression 559 
of proinflammatory cytokines (Hossain et al., 2017). In brains from transgenic mice 560 
model of Alzheimer’s disease, and postmortem brain tissues from patients with 561 
Alzheimer’s disease, Gnpat reduction via a similar mechanism has been observed 562 
(Hossain et al., 2017). Likewise, maternal infection, obesity, a high-fat diet, and 563 
restraint stress with bright-light exposure causes microglial cell activation and 564 
proinflammatory cytokine induction in the fetal and postnatal brain of rodents and 565 
monkeys, and maternal stress results in anxiety-like, depressive and aggressive behavior, 566 
and schizophrenia-like behavior in offspring (Bilbo and Tsang, 2010; Grayson et al., 567 
2010; Matrisciano et al., 2012; Diz-Chaves et al., 2013; Sasaki et al., 2013; Marques et 568 
al., 2015). In addition, activation of microglia is augmented in the brain including the 569 
anterior and orbitofrontal cortices in young adults with ASD, although the distribution 570 
pattern of activated microglia is similar to that of healthy control subjects, as 571 
determined by positron emission tomography (Suzuki et al., 2013). Maternal obesity 572 
before pregnancy is considered a risk factor for ADHD and ASD in humans (Andersen 573 
et al., 2017). Obesity is involved in elevated inflammatory mediators, e.g. IL-6, which 574 
induces Th17 cell differentiation. IL-17A secreted from Th17 may act to promote ASD 575 
by affecting fetal neurodevelopment (Wong and Hoeffer, 2018). These results suggest 576 
that brain inflammation plays a key role in behavior and that plasmalogen alters brain 577 
function through its anti-inflammatory effects. However, in our study, microglial cell 578 
activation was not altered by maternal undernutrition, at least for the adult offspring. 579 
Further, injection of plasmalogen PE (18:0p-22:6) to adult rats in the 40F group altered 580 




crossing and long time spent in the center area in the open-field test. 582 
Therefore, the hyperactivity of the rat offspring that were exposed to prenatal 583 
undernutrition may be attributable to the phospholipid composition of the brain rather 584 
than a direct effect of undernutrition on inflammatory reactions. Patients with RCDP, 585 
who display plasmalogen deficiency, have psychomotor retardation, and, in severely 586 
affected cases, they display microcephaly and cerebellar atrophy (Berger et al., 2016). 587 
Myelination and neuronal migration are thought to be causes of these features of 588 
patients with RCDP (Berger et al., 2016). RCDP type 1, type 2, and type 3 are caused by 589 
mutations of PEX7, GNPAT, and AGPS (Berger et al., 2016), respectively, all of which 590 
contribute to plasmalogen synthesis. In our study, expression of the latter two genes was 591 
elevated in the PFC. In RCDP fibroblasts with the PEX7 mutation, peroxisome targeting 592 
signal 2 protein, phytanoyl-CoA hydroxylase, and AGPS fail to be imported into the 593 
peroxisome (Yu et al., 2013). The PEX7 homozygous mutation has also been found in 594 
three ASD children whose unaffected siblings were heterozygous or wild-type within 595 
one family (Yu et al., 2013). Moreover, single-nucleotide-polymorphism fine mapping 596 
has shown that GNPAT is a candidate gene for schizophrenia, as is DISC1 (Liu et al., 597 
2006). These findings suggest that altered phospholipid metabolism, especially 598 
plasmalogen metabolism, may be involved in a person’s vulnerability to developmental 599 
and psychiatric disorders. Gnpat-knockout mice show delayed migration of granule cell 600 
precursors, enhanced apoptosis in the cerebellum, and hypo- and dysmyelination in the 601 
neocortex, cerebellum, and corpus callosum (Berger et al., 2016). Aberrant myelination 602 
may be one of the key factors in hyperactivity because MR findings suggest altered 603 
myelination in the white matter of adults with ADHD (Wu et al., 2017). Skin fibroblasts 604 




PE was maintained by an increase in other PEs (Dorninger et al., 2015). 606 
Polyunsaturated fatty acid (PUFA)-containing PlsEtn was reduced in these cells, and 607 
AA-containing, but not DHA-containing, PE species mainly compensated for PlsEtn 608 
deficiency (Dorninger et al., 2015). Similar findings have been observed for 609 
Gnpat-knockout mice; therefore, the ratio among essential PUFAs, as well as the ratio 610 
between PlsEtn and PE, may be critical for brain development, and a shift in these ratios 611 
may be the cause of the psychomotor retardation of patients with RCDP. In contrast, in 612 
our study, the levels of PE (18:0p-22:6) in the PFC and lyso PE (22:6) in CPu were both 613 
altered by exposure to prenatal undernutrition and PE (18:0p-22:6) injection. 614 
Additionally, injection of POPE, which is not a plasmalogen, did not alter rat behavior. 615 
A specific plasmalogen, such as PE (18:0p-22:6), and a specific DHA-containing PE, 616 
such as lyso PE (22:6), coupled with the level of plasmalogen in the brain may have a 617 
function for behavior. Exogenous administration of plasmalogen can be considered as a 618 
potential therapeutic strategy as it results in changes in the phospholipid composition of 619 
the brain. Regarding psychiatric disorders, the levels of PUFAs (e.g., PE22:5n6, 620 
PC20:3n6, and PC22:5n6) were lower in the white matter adjacent to the dorsolateral 621 
PFC of a patient with schizophrenia, while the level of PE20:2n6 was higher, and those 622 
of PE22:5n6, PC20:4n6, and PC22:5n6 were lower, in the white matter of the patient 623 
with bipolar disorder, despite no alterations in the plasmalogen level for both disorders 624 
(Ghosh et al., 2017). A subset combination of the head group (e.g., ethanolamine, 625 
choline, serine, or inositol) and a fatty acid tail, such as DHA or AA, which are 626 
incorporated into the phospholipid, may be critical to evoke the behavioral alterations 627 
that are characteristic of developmental or psychiatric disorders, and thus, could be a 628 




the trials, the administration of a PS supplement in a chewable tablet presentation 630 
improved ADHD for children aged 4–14 years (Hirayama et al., 2014). Exogenous PS 631 
can cross the blood–brain barrier (BBB) and function in the brain (Glade and Smith, 632 
2015). Regarding the delivery of plasmalogen into the brain across the BBB, liposomes 633 
with PC may be one of the preferred carriers, since the intravenous injection of 634 
liposomes has been the preferred delivery route for many previous studies (Vieira and 635 
Gamarra, 2016). However, PE has a cationic head, and the liposome may not be able to 636 
reach the brain because of nonspecific binding to the peripheral tissues and serum 637 
proteins (Vieira and Gamarra, 2016) if the ethanolamine head is exposed on the surface 638 
of the liposome membrane. In our study, the amount of PE (18:0p-22:6) was not altered 639 
in blood cells, suggesting that little of the injected PE was taken into the peripheral 640 
tissues during circulation in the brain before liposomes were captured by the liver. 641 
Plasmalogen is asymmetrically localized to the inner leaflet of the myelin membrane 642 
bilayer (Kirschner and Ganser, 1982), and plasmalogen-rich membranes tend to form 643 
non-lamellar inverse hexagonal structures compared with the membrane, which 644 
exclusively consists of diacyl phospholipids (Dean and Lodhi, 2017). The surface of the 645 
liposomes that were used in our study may be electrically neutral, and their nonspecific 646 
binding to the peripheral tissues and serum proteins may be prevented. 647 
In summary, maternal undernutrition during early pregnancy led to the hyperactivity of 648 
male rat offspring, and the behavioral changes observed may be, in part, caused by an 649 
alteration of the plasmalogen composition in the PFC, which was induced by the 650 
activation of the phospholipid synthetic pathway. Ethanolamine plasmalogen 651 
(18:0p-22:6) appears to play a critical role in behavior. Thus, plasmalogens could be 652 
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Figure legends 871 
 872 
Fig. 1 Study design and behavior of rat offspring subjected to prenatal undernutrition. 873 
(A) The experimental schedule is shown. The daily food intake was restricted from 874 
GD5.5 to GD10.5 or from the day of blastocyst implantation to the day just before the 875 
closure of the neural tube. (B–F) Behavioral tests at 8 weeks of age: male rat offspring 876 
exhibited hyperactivity in the LPD (n = 18), 50F (n = 13), and 40F (n = 17) groups 877 
compared with the offspring in the AL group (n = 32). (G–K) Behavioral tests at 12 878 
weeks of age: behavioral disturbances continued at 12 weeks of age in the LPD (n = 19) 879 
and 50F (n = 14) offspring compared with the AL offspring (n = 18). The statistical 880 
analysis was conducted using one-way ANOVA with Dunnett’s test. *p < 0.05, **p < 881 






Fig. 2 Preparation of the brain sections for MALDI-IMS (A) Rat brain sections were 885 
aligned between adjacent mouse brain sections (references). (B) Peak intensity of each 886 
phospholipid was corrected using the average peak intensity of the same phospholipid 887 
of the mouse reference sections. 888 
 889 
Fig. 3 Metabolome profiling of the plasma and CSF, and the observation of microglia in 890 
the PFC. (A) 2-aminoethanol and glycerol increased in the rat offspring exposed to 891 
prenatal undernutrition (plasma: n = 7 in AL and n =6 in 40F; CSF: n = 7 in AL and n = 892 
5 in 40F) (See also Figure 3-1). (B) The dotted area, which was the middle third of the 893 
box area, was examined. (C) Microglial cell activation in the PFC Iba1-positive 894 
microglia (green), CD11b-positive cells (red), and activated microglia (yellow) are 895 
shown in the PFC of the offspring of the AL and 40F groups. Scale bar, 20 mm. (D) The 896 
densities of microglia and activated microglia were not increased in the PFC of 40F (n = 897 
8) offspring compared with AL (n = 8) offspring. (E) The ratio of the number of 898 
activated microglia to the total number of microglia was not altered by prenatal 899 
undernutrition. *p < 0.05, **p < 0.01, Student’s t-test. 900 
 901 
Fig. 4 Biosynthetic pathway of plasmalogens and diacyl phospholipids. The enzymes 902 
related to phospholipid synthesis, with intermediates, are shown. The genes indicated 903 
by underlined bold italic characters were activated. Abbreviations of the 904 
genes are noted as follows: Hk:Hexokinase, GPI:Glucose-6-phosphate isomerase, 905 
Pfk:Phosphofructokinase, aldoiase:Fructose-bisphosphate aldoiase, 906 
Gpd:Glycerol-3-phosphate dehydrogenase, Far:fatty acyl-CoA reductase, Gk:Glycerol 907 




synthase, ADHAPAR:Alkyl/acyl-glycerophosphate acyltransferase, Plpp:Phosphatidic 909 
acid phosphatase, Cept:Choline/ethanolamine phosphotransferase, 910 
Plasmenylethanolamine desaturase, Ept:Ethanolamine phosphotransferase, 911 
Chpt:Choline phosphotransferase, Gpat:Glycerol-3-phosphate acyltransferase, Lpcat: 912 
LysoPA-acyltransferase, Chk:choline kinase, Etnk:Ethanolamine kinase, 913 
Pemt:Phosphoethanolamine N-methyltransferase, Pcyt:Phospate cytidyltransferase, 914 
Pisd:Phosphatidylserine decarboxylase, Ptdss:Phosphatidylserine synthase, 915 
CDS:CDP-diacylglycerol synthase, Sgms:Sphingomyelin synthase, 916 
Smpd:Sphingomyelin phosphodiesterase, Pis:Phosphatidylinositol synthase, 917 
Pgps:Phosphatidylglycerophosphate synthase, Cls:Cardiolipin synthase, 918 
PE:Phosphatidylethanolamine, PC: Phosphatidylcholine, PS: Phosphatidylserine, PI: 919 
Phosphatidylinositol, CL:Cardiolipin, PG, Phosphatidylglycerol, SM:Sphingomyelin. 920 
 921 
Fig. 5 Gene expression of the enzymes related to phospholipid synthesis and 922 
phospholipid composition of the rat brain. (A) The area examined by gene expression 923 
analysis (B) The ratios of the expression levels of the enzymes in the synthetic pathway 924 
of plasmalogens and diacyl phospholipids in the PFC, NAcc, and CPu for the 925 
40F-group offspring (n = 8) were compared with those for the AL-group offspring (n = 926 
8) (See Figure 5-1). (C) The area examined by MALDI-IMS. The dotted areas were 927 
examined in the PFC, NAcc, and CPu. In a section of the PFC, the dotted area is the 928 
middle third of the box area indicated by the solid line. Signal intensity was indicated 929 
by color. (D) The ratios of peak intensities of phospholipids of 40F offspring (n = 7) to 930 
those of AL offspring (n = 7) are shown (See Figure 5-2). (E) The peaks of product ions 931 




*p < 0.05, **p < 0.01, Student’s t-test. 933 
 934 
Fig. 6 Behavioral tests and phospholipid composition in the brain of the rats injected 935 
with PE. (A) The experimental schedule of the liposome injection at 14 weeks of age. 936 
Changes in the behavior of rats by using the open-field test after (B) PE (18:0p-22:6) 937 
(PEL: n = 6, CL: n = 7), or (C) POPE injection (POPEL: n = 5, CL: n = 5, saline: n = 4) 938 
were examined by ANCOVA. Similarly, behavioral changes evaluated according to the 939 
elevated plus maze test after (D) PE (18:0p-22:6) (PEL: n = 6, CL: n = 6), or (E) POPE 940 
injection (POPEL: n = 5, CL: n = 5, saline: n = 4) were examined. (F) The ratios of peak 941 
intensities of phospholipids in the brains of PEL-injected rats (n = 4) significantly 942 
increased compared with those of CL-injected rats (n = 4) using Student’s t-test (See 943 
also Figure 6-1). The increased ratio of peak intensity of PE (18:0p-22:6) in the PFC of 944 
PEL-injected rats was verified in an additional experiment (See Figure 6-2). (G) The 945 
ratio of PE (18:0p-22:6) to total lipids in the blood cells was compared among CL PEL 946 
and saline groups using one-way ANOVA with Tukey’s HSD test. *p < 0.05, ns: not 947 
significant. 948 
 949 
Fig. 3-1 Metabolomics of the plasma and CSF in male offspring aged 9 weeks. All data 950 
identified in this study are shown. The peak height of a particular ion for each 951 
metabolite was normalized to the peak height of the specified ion of 2-isopropylmalic 952 
acid in metabolic profiling. *p < 0.05, Student’s t-test, ND: not detected. 953 
 954 
Fig. 5-1 Gene expression profiles in male offspring aged 9 weeks. Comparative Cq 955 




ND: not detected, NE: not examined. 957 
 958 
Fig. 5-2 Change in phospholipid composition in PFC, NAcc, and CPu by undernutrition. 959 
All data examined in this study are shown. *p < 0.05, Student’s t-test. 960 
 961 
Fig. 6-1 Phospholipid composition in PFC, NAcc, and CPu of the rats injected with 962 
liposomes. All data examined in this study are shown. *p < 0.05, Student’s t-test. 963 
 964 
Fig. 6-2 Phospholipid composition in PFC of the rats injected with liposomes in the 965 
verification experiment. To verify whether PE (18:0p-22:6) was elevated in the brain 966 
following PE injection, phospholipid composition was analyzed in PFC sections of male 967 
rats in the PEL (n = 5) and CL (n = 5) after two shots of PE (18:0p-22:6) using the 968 
method described in the Materials and Methods section. This experiment was conducted 969 
separately from the PEL injection study in Fig. 6F. PE (18:0p-22:6) significantly 970 
increased in the PFC of the rats injected with PEL liposomes (p = 0.032, d = 1.83).  *p 971 










Table 2 Allocation of experimental groups 
Treatment Experiment Age (weeks)  
Under nutrition Open-field test 8 AL, 40F, 50F, LPD 
 Open-field test 12 AL, 50F, LPD 
 Metabolic profiling (plasma, CSF) 9 AL, 40F 
 Counting microglial cells (PFC) 9 AL, 40F 
 Gene expression (PFC, NAcc, CPu) 9 AL, 40F 
 MALDI-IMS (PFC, NAcc, CPu) 9 AL, 40F 
Liposome injection Open-field test 8 and 14 CL, PEL, POPEL, saline 
 Elevated plus maze test 8 and 14 CL, PEL, POPEL, saline 
 MALDI-IMS (PFC, NAcc, CPu, blood cells) 14 CL, PEL 
AL: ad libitum group, 40F or 50F: the group fed 40% or 50% of the daily food intake of the AL, respectively, LPD: low protein diet 
group 
CL, PEL, POPEL, or saline: the group injected with control, PE (18:0p-22:6), or POPE liposome, or saline 
 
 1 
Table 3 Body weight of the offspring 
Values are means ± SD, *p < 0.05 vs AL (One-way ANOVA with Dunnett’s test) 
Group 
Body weight (g) 
9 weeks of age  12 weeks of age 
AL 271.4 ± 26.5 (n = 32) 315.5 ± 26.0 (n = 18) 
50F  248.7 ± 20.6* (n = 18) 317.7 ± 26.2 (n = 18) 
40F 267.8 ± 28.8 (n = 18) Not measured 
LPD  250.4 ± 17.3* (n = 19) 325.7 ± 18.5 (n = 19) 
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Table 4 Change in amounts of DHA- or AA-containing phospholipids in PFC, NAcc, and CPu by undernutrition 
Phospholipid sn1_sn2 
PFC NAcc CPu 
AL 40F AL 40F AL 40F 
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
Lyso PE_AA 20:4 (Acyl) 3.86 ± 1.20 6.30 ± 2.70 3.60 ± 0.67 2.60 ± 0.77* 3.76 ± 0.57 2.75 ± 0.39* 
Lyso PE_DHA 22:6 (Acyl) 2.54 ± 0.84 3.67 ± 1.17 2.23 ± 0.46 1.70 ± 0.26* 2.48 ± 0.33 1.92 ± 0.38* 
PE_AA_Pls 16:0p-20:4 (Alkenyl_acyl) 2.83 ± 0.95 3.97 ± 1.70 4.52 ± 1.46 4.52 ± 0.86 3.27 ± 0.74 3.46 ± 0.76 
 18:1p-20:4 (Alkenyl_acyl) 2.07 ± 0.72 2.48 ± 1.03 2.15 ± 0.41 2.02 ± 0.43 1.94 ± 0.27 1.90 ± 0.42 
PE_AA_Acyl 18:1-20:4 (Alkyl_acyl) 2.71 ± 0.86 3.39 ± 1.31 3.65 ± 0.82 3.38 ± 0.63 2.89 ± 0.50 3.00 ± 0.62 
 18:0-20:4 (Alkyl_acyl) 2.95 ± 0.73 4.29 ± 1.87 3.83 ± 0.95 3.21 ± 0.72 3.14 ± 0.76 2.97 ± 0.59 
 18:2-20:4 (Diacyl) 1.37 ± 0.47 1.67 ± 0.67 1.21 ± 0.22 1.19 ± 0.26 1.18 ± 0.17 1.19 ± 0.27 
 18:1-20:4 (Diacyl) 1.67 ± 0.54 2.10 ± 0.88 1.64 ± 0.31 1.45 ± 0.26 1.67 ± 0.20 1.49 ± 0.27 
 18:0-20:4 (Diacyl) 1.84 ± 0.56 2.35 ± 0.96 2.38 ± 0.32 2.11 ± 0.42 1.74 ± 0.19 1.72 ± 0.40 
PE_DHA_Pls 18:0p-22:6 (Alkenyl_acyl) 1.41 ± 0.43 9.39 ± 4.62* 1.74 ± 0.32 1.67 ± 0.30 1.79 ± 0.28 1.75 ± 0.32 
 18:1p-22:6 (Alkenyl_acyl) 1.30 ± 0.36 1.63 ± 0.65 1.28 ± 0.24 1.16 ± 0.20 1.34 ± 0.26 1.26 ± 0.19 
 20:1p-22:6 (Alkenyl_acyl) 3.11 ± 1.38 3.46 ± 0.85 2.09 ± 0.69 1.77 ± 0.82 2.48 ± 1.14 2.13 ± 0.49 
PE_DHA_Acyl 16:1-22:6 (Diacyl) 1.36 ± 0.38 1.64 ± 0.84 1.80 ± 0.41 1.55 ± 0.26 1.86 ± 0.24 1.66 ± 0.20 
 18:0-22:6 (Alkyl_acyl) 1.67 ± 0.46 2.19 ± 0.92 1.94 ± 0.45 1.70 ± 0.34 1.93 ± 0.35 1.93 ± 0.41 
 18:2-22:6 (Diacyl) 1.75 ± 0.66 2.27 ± 1.09 1.56 ± 0.29 1.37 ± 0.31 1.93 ± 0.32 1.73 ± 0.42 
 18:0-22:6 (Diacyl) 1.31 ± 0.42 1.67 ± 0.63 1.46 ± 0.28 1.46 ± 0.31 1.44 ± 0.22 1.48 ± 0.31 
 20:1-22:6 (Diacyl) 3.00 ± 1.17 3.65 ± 1.96 2.72 ± 0.71 1.76 ± 0.77* 3.08 ± 0.91 2.69 ± 1.20 
 20:0-22:6 (Diacyl) 2.16 ± 0.85 3.42 ± 1.71 3.28 ± 1.08 2.58 ± 1.73 4.47 ± 1.45 3.74 ± 2.08 
 22:6-22:6 (Diacyl) 1.86 ± 0.72 2.35 ± 0.98 1.87 ± 0.35 1.76 ± 0.40 1.74 ± 0.29 1.73 ± 0.39 
 22:6-24:6 (Diacyl) 2.74 ± 2.55 2.90 ± 0.55 1.41 ± 0.40 1.05 ± 0.28 3.52 ± 1.30 3.23 ± 0.81 
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 24:4-22:6 (Diacyl) 2.97 ± 1.20 3.55 ± 1.41 1.74 ± 0.58 2.01 ± 1.46 2.24 ± 0.80 2.49 ± 1.23 
PS_AA_Acyl 18:1-20:4 (Diacyl) 2.00 ± 0.63 2.94 ± 1.50 3.50 ± 1.28 3.16 ± 0.76 6.01 ± 1.91 6.38 ± 1.87 
PS_DHA_Acyl 16:0-22:6 (Diacyl) 1.46 ± 0.47 2.39 ± 1.13 3.91 ± 0.94 3.35 ± 0.68 7.26 ± 1.62 7.21 ± 1.56 
 18:1-22:6 (Diacyl) 2.64 ± 0.97 3.12 ± 1.57 1.73 ± 0.63 1.63 ± 0.43 2.14 ± 0.46 1.88 ± 0.38 
 20:0-22:6 (Diacyl) 2.11 ± 0.67 4.29 ± 2.46 2.12 ± 0.92 1.89 ± 0.54 2.72 ± 1.02 2.47 ± 0.50 
 22:4-22:6 (Diacyl) 2.10 ± 1.19 3.56 ± 2.64 1.56 ± 0.22 1.56 ± 0.44 1.91 ± 0.29 1.77 ± 0.45 
PS_AA_DHA 20:4-22:6 (Diacyl) 2.09 ± 0.77 2.52 ± 1.08 2.02 ± 0.57 1.82 ± 0.44 2.01 ± 0.69 2.16 ± 0.77 
Lyso PI_AA 20:4 (Acyl) 3.40 ± 1.67 4.53 ± 2.83 4.39 ± 1.03 4.06 ± 2.43 4.22 ± 0.64 3.99 ± 2.32 
PI_AA_Acyl 16:1-20:4 (Diacyl) 5.79 ± 8.33 4.14 ± 2.30 1.92 ± 0.39 1.87 ± 0.50 2.44 ± 0.66 2.21 ± 0.22 
 16:0-20:4 (Diacyl) 2.07 ± 0.84 2.38 ± 1.07 4.77 ± 7.19 1.44 ± 0.49 4.67 ± 6.92 1.52 ± 0.50 
 18:0-20:4 (Alkyl_acyl) 2.83 ± 1.19 2.67 ± 1.19 1.98 ± 0.56 1.82 ± 0.28 2.27 ± 0.53 2.11 ± 0.30 
 18:1-20:4 (Diacyl) 1.89 ± 0.77 2.23 ± 1.01 1.70 ± 0.36 1.42 ± 0.49 1.59 ± 0.32 1.43 ± 0.42 
 18:0-20:4 (Diacyl) 2.28 ± 0.83 2.79 ± 1.19 2.71 ± 0.77 2.66 ± 0.78 2.80 ± 0.39 2.69 ± 0.75 
PI_DHA_Acyl 18:0-22:6 (Diacyl) 2.22 ± 0.87 2.82 ± 1.80 1.17 ± 0.33 1.17 ± 0.35 1.64 ± 0.33 1.34 ± 0.56 
*p < 0.05 
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Table 5 Change in amounts of DHA- or AA-containing phospholipids in PFC, NAcc, and CPu of the rats injected with liposomes 
Phospholipid sn1_sn2 
PFC NAcc CPu 
PEL CL PEL CL PEL CL 
Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
Lyso PE_AA 20:4 (Acyl) 1.94 ± 0.21 2.17 ± 0.24 1.44 ± 0.79 2.15 ± 0.88 1.31 ± 0.15 1.87 ± 0.58 
Lyso PE_DHA 22:6 (Acyl) 1.29 ± 0.23 1.55 ± 0.09 1.00 ± 0.45 1.24 ± 0.28 0.88 ± 0.19* 1.55 ± 0.32 
PE_AA_Pls 16:0p-20:4 (Alkenyl_acyl) 4.29 ± 0.71 3.66 ± 0.59 3.02 ± 1.03 3.36 ± 0.50 2.19 ± 0.43 2.58 ± 0.62 
 18:1p-20:4 (Alkenyl_acyl) 2.25 ± 0.41 2.07 ± 0.32 1.13 ± 0.36 1.36 ± 0.14 1.06 ± 0.24 1.24 ± 0.20 
PE_AA_Acyl 18:1-20:4 (Alkyl_acyl) 3.22 ± 0.54 2.70 ± 0.58 2.26 ± 0.73 2.48 ± 0.19 1.88 ± 0.42 2.14 ± 0.36 
 18:0-20:4 (Alkyl_acyl) 3.11 ± 0.58 2.28 ± 0.27 2.11 ± 0.65 2.56 ± 0.32 1.82 ± 0.40 2.30 ± 0.29 
 18:2-20:4 (Diacyl) 1.87 ± 0.28 1.50 ± 0.24 0.65 ± 0.18 0.73 ± 0.05 0.68 ± 0.13 0.78 ± 0.10 
 18:1-20:4 (Diacyl) 1.69 ± 0.39 1.43 ± 0.28 1.02 ± 0.24 1.12 ± 0.17 1.06 ± 0.20 1.19 ± 0.24 
 18:0-20:4 (Diacyl) 2.60 ± 0.56 1.97 ± 0.60 1.30 ± 0.35 1.50 ± 0.12 1.07 ± 0.20 1.22 ± 0.16 
PE_DHA_Pls 18:0p-22:6 (Alkenyl_acyl) 2.62 ± 0.31* 1.88 ± 0.08 1.06 ± 0.30 1.18 ± 0.05 1.08 ± 0.18 1.18 ± 0.13 
 18:1p-22:6 (Alkenyl_acyl) 2.13 ± 0.31 1.99 ± 0.16 0.73 ± 0.23 0.88 ± 0.11 0.84 ± 0.15 1.00 ± 0.15 
 20:1p-22:6 (Alkenyl_acyl) 2.99 ± 1.29 2.39 ± 0.22 1.00 ± 0.46 1.04 ± 0.26 1.33 ± 0.30 1.92 ± 0.64 
PE_DHA_Acyl 16:1-22:6 (Diacyl) 1.10 ± 0.31 1.03 ± 0.19 0.97 ± 0.27 1.20 ± 0.28 1.26 ± 0.26 1.32 ± 0.27 
 18:0-22:6 (Alkyl_acyl) 2.52 ± 0.38 1.87 ± 0.35 0.99 ± 0.31 1.23 ± 0.08 1.17 ± 0.22 1.33 ± 0.15 
 18:2-22:6 (Diacyl) 1.29 ± 0.24 1.27 ± 0.20 0.86 ± 0.17 1.08 ± 0.22 1.04 ± 0.34 1.31 ± 0.31 
 18:0-22:6 (Diacyl) 1.63 ± 0.32 1.28 ± 0.33 0.82 ± 0.20 0.92 ± 0.10 0.84 ± 0.14 0.93 ± 0.11 
 20:1-22:6 (Diacyl) 1.94 ± 0.36 2.05 ± 0.46 0.88 ± 0.31 1.08 ± 0.24 0.92 ± 0.44 1.19 ± 0.39 
 20:0-22:6 (Diacyl) 1.85 ± 0.46 2.12 ± 0.21 1.90 ± 1.23 3.23 ± 0.69 2.68 ± 0.40 3.44 ± 0.58 
 22:6-22:6 (Diacyl) 1.91 ± 0.41 1.71 ± 0.40 1.05 ± 0.32 1.31 ± 0.13 1.02 ± 0.21 1.20 ± 0.21 
 22:6-24:6 (Diacyl) 3.74 ± 1.60* 7.77 ± 0.78 0.61 ± 0.28 0.93 ± 0.59 1.68 ± 0.44 2.23 ± 0.50 
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 24:4-22:6 (Diacyl) 2.28 ± 0.22* 2.98 ± 0.19 1.08 ± 0.75 1.54 ± 0.20 0.98 ± 0.22 1.43 ± 0.55 
PS_AA_Acyl 18:1-20:4 (Diacyl) 1.04 ± 0.14 1.34 ± 0.14 1.73 ± 0.67 2.03 ± 0.25 2.77 ± 0.69 3.32 ± 0.49 
PS_DHA_Acyl 16:0-22:6 (Diacyl) 0.60 ± 0.03* 0.91 ± 0.04 1.60 ± 0.62 2.41 ± 1.04 3.56 ± 0.92 4.71 ± 0.98 
 18:1-22:6 (Diacyl) 1.80 ± 0.39 1.58 ± 0.18 1.44 ± 0.79 1.23 ± 0.15 1.26 ± 0.41 1.55 ± 0.29 
 20:0-22:6 (Diacyl) 1.74 ± 0.29 2.36 ± 0.49 1.00 ± 0.45 1.65 ± 0.45 1.63 ± 0.36 1.69 ± 0.45 
 22:4-22:6 (Diacyl) 7.68 ± 2.36 5.82 ± 1.23 3.02 ± 1.03 1.21 ± 0.25 1.16 ± 0.30 1.37 ± 0.22 
PS_AA_DHA 20:4-22:6 (Diacyl) 2.33 ± 0.40 2.51 ± 0.32 1.13 ± 0.36 1.54 ± 0.49 1.14 ± 0.34 1.22 ± 0.25 
Lyso PI_AA 20:4 (Acyl) 2.80 ± 0.19 3.27 ± 0.32 2.26 ± 0.73 1.33 ± 0.22 1.13 ± 0.31 1.34 ± 0.30 
PI_AA_Acyl 16:1-20:4 (Diacyl) 1.88 ± 0.47 1.31 ± 0.08 2.11 ± 0.65 1.71 ± 0.11 1.49 ± 0.42 1.67 ± 0.43 
 16:0-20:4 (Diacyl) 2.08 ± 0.43 1.88 ± 0.37 0.65 ± 0.18* 1.32 ± 0.22 0.94 ± 0.21 1.32 ± 0.19 
 18:0-20:4 (Alkyl_acyl) 2.13 ± 0.37 2.63 ± 0.45 1.02 ± 0.24 1.25 ± 0.15 1.17 ± 0.31 1.23 ± 0.25 
 18:1-20:4 (Diacyl) 2.43 ± 0.24 2.27 ± 0.33 1.30 ± 0.35 1.11 ± 0.23 0.95 ± 0.30 1.11 ± 0.33 
 18:0-20:4 (Diacyl) 2.41 ± 0.38 2.25 ± 0.35 1.11 ± 0.20 1.84 ± 0.22 1.49 ± 0.32 1.70 ± 0.30 
PI_DHA_Acyl 18:0-22:6 (Diacyl) 1.64 ± 0.12 1.75 ± 0.29 0.73 ± 0.23 1.96 ± 0.16 1.43 ± 0.58 1.54 ± 0.17 
*p < 0.05 
